This year, all three prizes, as well as the “best abstract of the conference” go to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and St. Anna Children’s Hospital!
…and the ÖGMBT Best Talk Award goes to: Eva König!
…and the ÖGMBT Best Talk Award goes to: Eva König! Read More »
Socializing, getting further education and screening job offers: This year’s Life Science Career Fair of the ÖGMBT offered a wide range of opportunities for students and graduates.
A great success! Dr. Eva König, principal investigator at St. Anna CCRI, is honored with the Heribert-Konzett-Prize of the Austrian Pharmacological Society (APHAR) for her scientific work on the interaction between immune and cancer cells. The prize is awarded to recognize the achievements of young scientists already conducting independent research in the field of experimental and clinical pharmacology and to encourage their further development.
Eva König wins Heribert-Konzett-Prize! Read More »
Evolution 2.0: What makes cancer more malignant (Vienna, 23.09.2022) Congratulations! A paper has just been published in the top journal Nature Genetics, with the participation of Dr. Sabine Taschner-Mandl and Dr. Marie Bernkopf from St. Anna CCRI. The authors of this outstanding paper show that random inheritance patterns of cancer genes outside the chromosome, i.e. the scaffold
Evolution 2.0: What makes cancer more malignant Read More »
St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! (Vienna, 20.09.2022) Well done! First place at the Life Science Research Awards Austria 2022 in the category Excellence and Societal Impact – Peter Peneder from Dr. Eleni Tomazou´s tumor epigenetics research group at St. Anna CCRI convinced the jury of the Austrian Society for Molecular Biosciences and
St. Anna CCRI epigenetics researcher Peter Peneder wins ÖGMBT-award! Read More »
Nerve healing: neighboring cells become police force – and could make tumors benign (Vienna, 15.09.2022) Scientists from St. Anna Children´s Cancer Research Institute (St. Anna CCRI) discovered a completely new function of the cells that surround nerve fibers: so-called Schwann cells not only attract immune cells to initiate nerve healing, but also behave like a “police force”
Nerve healing: neighboring cells become police force – and could make tumors benign Read More »
Scientists off the record: In our summer interview series, St. Anna Children’s Cancer Researcher Florian Halbritter shares not only his summer reading shortlist, but also his best advice to bring forward great ideas.
Florian Halbritter: “Be open and curious, listen, learn, adapt, and improve.” Read More »
Pediatric cancer researchers publish collection of leukemia reviews in top journal “Frontiers in Pediatrics”.
According to the authors, new therapies could spare some children a stem cell transplantation.
Childhood Leukemia treatment 2022: where we are now and what it takes Read More »
September is Childhood Cancer Awareness Month – a month dedicated to remind us of the dire need to find more and better cures for this devastating disease.
Gold and Brave against Childhood Cancer Read More »
St. Anna Childhood Cancer Researcher Michael Dworzak explains which question drives him, what matters in research/life and how to keep cool on hot summer days.
Scientists off the record: “… coincidentally stumbled upon leukemia cells” Read More »
St. Anna Children’s Cancer Researcher Sabine Taschner-Mandl strives to improve the treatment of childhood nerve tumors. We asked what arouses her curiosity and how she spends her summer holidays.
This year’s 1000 ideas program of FWF promotes another two of St. Anna CCRI’s “completely new, daring or particularly original research ideas that lie outside the current scientific understanding”. Florian Halbritter’s new approach aims to integrate machine learning directly into the experimental design and execution of manufacturing specific cell types from stem cells – with the ultimate goal to reprogram even cancer cells. Artem Kalinichenko, who was also awarded a 1000 ideas grant, is targeting abnormal tumor metabolism by identifying cancer-derived metabolites, drugs and drug metabolites that trigger an immune reaction, which could later be exploited for immunotherapy.
Two St. Anna CCRI projects selected for FWF’s 1000 ideas program Read More »
Scientists off the record: St. Anna Children’s Cancer Researcher René Geyeregger reveals how he spends his summer vacation, what he is curious about and what drives him in research.
To find vulnerabilities of cancers that are driven by MYC, a protein known for its potential to induce tumor growth, is the goal of a new project funded by the Austrian Science Fund FWF. Davide Seruggia from St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and colleagues aim to deactivate this key cancer regulator by targeting components of SAGA, a protein complex tightly linked to MYC. Since pediatric leukemia and neuroblastoma, two of the most common childhood cancers are known to be driven by MYC, establishing new strategies to interrupt its activity in cancer cells is of utmost importance.
Davide Seruggia earns FWF Stand-Alone funding Read More »
To kick off our new interview series, we asked St. Anna Children’s Cancer Researcher Eva König how she copes with midsummer temperatures, what shaped her life as a researcher, and which book should not be missing in her vacation luggage.
Scientists off the record: How Eva König keeps cool on midsummer days Read More »
